San Francisco, CA6 Active Studies

Pediatric Cancer Clinical Trials in San Francisco, CA

Find 6 actively recruiting pediatric cancer clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

6
Active Trials
5
Sponsors
1,636
Enrolling

Recruiting Pediatric Cancer Studies in San Francisco

About Pediatric Cancer Clinical Trials in San Francisco

Pediatric cancers include a wide range of cancers occurring in children and adolescents, with leukemia, brain tumors, and lymphoma being most common. Overall cure rates have improved dramatically to about 80%. Treatment includes chemotherapy, surgery, radiation, and newer immunotherapies.

There are currently 6 pediatric cancer clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 1,636 participants. Research is being sponsored by New Approaches to Neuroblastoma Therapy Consortium, University of California, San Diego, St. Jude Children's Research Hospital and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pediatric Cancer Clinical Trials in San Francisco — FAQ

Are there pediatric cancer clinical trials in San Francisco?

Yes, there are 6 pediatric cancer clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What pediatric cancer treatments are being tested?

The 6 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for pediatric cancer.

Data updated July 13, 2026 from ClinicalTrials.gov